Evidence map›Paper›PMID 25140823›Full record

ArticlePloS one2014

HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats.

Phoebe Lin, Mary Bach, Mark Asquith, Aaron Y Lee, Lakshmi Akileswaran, Patrick Stauffer, Sean Davin, Yuzhen Pan, Eric D Cambronne, Martha Dorris and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 2 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 2 syntheses or guidelines pooled it, 247 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. HLA-CPediatric diabetes · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 2 countries.

Phoebe LinCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Mary BachDivision of Rheumatology, University of Washington, VA Medical Center, Seattle, Washington, United States of America.
Mark AsquithDivision of Rheumatology, Oregon Health & Science University, Portland, Oregon, United States of America.
Aaron Y LeeMoorfield's Eye Institute of London, London, United Kingdom.
Lakshmi AkileswaranDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States of America.
Patrick StaufferCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Sean DavinCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Yuzhen PanCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Eric D CambronneDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon, United States of America.
Martha DorrisDepartment of Rheumatology, University of Texas Southwestern, Dallas, Texas, United States of America.
Justine W DebeliusUniversity of Colorado Boulder, Boulder, Colorado, United States of America.
Christian L LauberUniversity of Colorado Boulder, Boulder, Colorado, United States of America.
Gail AckermannUniversity of Colorado Boulder, Boulder, Colorado, United States of America.
Yoshiki V BaezaUniversity of Colorado Boulder, Boulder, Colorado, United States of America.
Tejpal GillPediatric Translational Research Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Baltimore, Maryland, United States of America.
Rob KnightUniversity of Colorado Boulder, Boulder, Colorado, United States of America; Howard Hughes Medical Institute, University of Colorado Boulder, Boulder, Colorado, United States of America.
Robert A ColbertPediatric Translational Research Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Baltimore, Maryland, United States of America.
Joel D TaurogDepartment of Rheumatology, University of Texas Southwestern, Dallas, Texas, United States of America.
Russell N Van GelderDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States of America.
James T RosenbaumCasey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States of America; Division of Rheumatology, Oregon Health & Science University, Portland, Oregon, United States of America; Dever's Eye Institute, Portland, Oregon, United States of America.
Oregon Health & Science University · USUniversity of Colorado Boulder · USThe University of Texas Southwestern Medical Center · USUniversity of Washington · USLegacy Health · USMoorfields Eye Hospital NHS Foundation Trust · GBNational Institute of Arthritis and Musculoskeletal and Skin Diseases · USNational Institutes of Health · USUniversity of Washington Medical Center · US

Funding

Pathogenic Mechanisms in SpondyloarthritisZIAAR041184 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$47.6M
Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI JAMES Bryant HURLEY · 1985 to 2026
$23.5M
RESEARCH TRAINING IN RHEUMATOLOGYT32AR007108 · NIAMS · UNIVERSITY OF WASHINGTON · PI Shaun Jackson, Tomas M Mustelin · 1986 to 2026
$6.6M
The effect of the microbiome on the development and severity of uveitisK08EY022948 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LIN, PHOEBE · 2013 to 2017
$1.0M
Howard Hughes Medical InstituteIntramural NIH HHSNEI NIH HHS K08 EY022948NEI NIH HHS K08EY022948NEI NIH HHS NIH P30 EY001730NEI NIH HHS P30 EY001730NIAMS NIH HHS NIH T32 AR 007108NIAMS NIH HHS T32 AR007108NIAMS NIH HHS Z01 AR041184Wellcome Trust
6 · The paper itself

Abstract

The HLA-B27 gene is a major risk factor for clinical diseases including ankylosing spondylitis, acute anterior uveitis, reactive arthritis, and psoriatic arthritis, but its mechanism of risk enhancement is not completely understood. The gut microbiome has recently been shown to influence several HLA-linked diseases. However, the role of HLA-B27 in shaping the gut microbiome has not been previously investigated. In this study, we characterize the differences in the gut microbiota mediated by the presence of the HLA-B27 gene. We identified differences in the cecal microbiota of Lewis rats transgenic for HLA-B27 and human β2-microglobulin (hβ2m), compared with wild-type Lewis rats, using biome representational in situ karyotyping (BRISK) and 16S rRNA gene sequencing. 16S sequencing revealed significant differences between transgenic animals and wild type animals by principal coordinates analysis. Further analysis of the data set revealed an increase in Prevotella spp. and a decrease in Rikenellaceae relative abundance in the transgenic animals compared to the wild type animals. By BRISK analysis, species-specific differences included an increase in Bacteroides vulgatus abundance in HLA-B27/hβ2m and hβ2m compared to wild type rats. The finding that HLA-B27 is associated with altered cecal microbiota has not been shown before and can potentially provide a better understanding of the clinical diseases associated with this gene.

Indexed as

MicrobiotaAnimalsbeta 2-MicroglobulinCecumHLA-B27 AntigenHumansMaleRatsRats, Inbred Lewbeta 2-MicroglobulinHLA-B27 Antigen

Identifiers

PMID25140823
PMCPMC4139385
OpenAlexW2054947125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.